During the past decade, National Institute of Clinical Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Institute of Clinical Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Angiotech Pharmaceuticals" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Repros Therapeutics Inc." with 2 trials sponsored and "Abbott" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Clinical Research" #1 collaborator was "Harvard University" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Clinical Research" are "Healthy Volunteers" (2 trials), "Uterine Fibroids" (2 trials), "Anemia" (1 trials), "CKD Stage 3" (1 trials) and "CKD Stage 4" (1 trials). Many other conditions were trialed in "National Institute of Clinical Research" in a lesser frequency.

Most popular intervention types in "National Institute of Clinical Research" are "Drug" (14 trials), "Biological" (3 trials), "Device" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Epoetin Hospira" (2 trials), "Calcifediol Oral Capsule" (1 trials), "Calcifediol Oral Product" (1 trials) and "Cholecalciferol" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Clinical Research" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "National Institute of Clinical Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in National Institute of Clinical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Clinical Research, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".